Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
July 19, 2023 06:00 ET | Catalyst Pharmaceuticals, Inc.
Vamorolone is a Promising Best-In-Class Dissociative Anti-Inflammatory Steroid Treatment for Duchenne Muscular Dystrophy Synergistic Novel Asset Leverages Catalyst's Expertise and Bolsters...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Teams Up with Patients and Advocacy Groups to Ring Nasdaq Opening Bell on Rare Disease Day 2022
February 24, 2022 08:03 ET | Catalyst Pharmaceuticals, Inc.
Ceremony Recognizes Importance of Biopharma Industry and Advocacy Group Collaboration to Address Needs for New Treatments in Orphan and Rare Disorders Together, Will Ring the Nasdaq Opening Bell to...
Allsup Joins NORD To Address COVID-19 Concerns
July 29, 2020 13:34 ET | Allsup
Belleville, Illinois, July 29, 2020 (GLOBE NEWSWIRE) -- Patients and families affected by rare diseases are gravely concerned about COVID-19 and its impact on their health and financial well-being,...
RAPS Honors Winners
RAPS Honors Winners of Founder’s Award, Community Leadership Award and New Patient-Centered Health Award
September 24, 2019 09:33 ET | Regulatory Affairs Professionals Society (RAPS)
Philadelphia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- The Regulatory Affairs Professionals Society (RAPS) today recognized five distinguished individuals and one leading advocacy organization for...
Social Security Adds Five Conditions to Compassionate Allowances (CAL) Program
August 29, 2018 14:34 ET | Allsup
Belleville, Illinois, Aug. 29, 2018 (GLOBE NEWSWIRE) -- The Social Security Administration (SSA) announced the addition of five conditions to the Compassionate Allowances (CAL) program on Aug. 20....
BioNews Services Put
BioNews Services Puts Sharp Focus on Rare Disease Day 2018
February 28, 2018 08:45 ET | BioNews Services
DALLAS, Feb. 28, 2018 (GLOBE NEWSWIRE) -- BioNews Services, the leading online health, science and research publisher serving patients with rare diseases, is using its editorial resources this month...
Aegerion Pharmaceuti
Aegerion Pharmaceuticals Observes Rare Disease Day
February 28, 2013 08:00 ET | Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 28, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...